SIIFIC Wellness Fund Invests in Toregem BioPharma— Advancing the World’s First Drug Discovery Program for Tooth Regeneration Toward a Society Where Everyone Can Chew, Speak, and Smile with Their Natural Teeth —

On April 27, 2026, Japan Social Innovation and Investment Foundation (Chair of Executive Committee: Shuichi Ohno; Head Office: Minato-ku, Tokyo; hereinafter “SIIF”), through the SIIFIC Wellness Investment Limited Partnership (hereinafter “SIIFIC Wellness Fund”), jointly managed with SIIF Impact Capital Inc. (Representative Director: Kazuhiro Umeda; Location: Shibuya-ku, Tokyo; hereinafter “SIIFIC”), subscribed to a third-party allotment of shares issued by Toregem BioPharma Co., Ltd. (Representative Director: Honoka Kisou; Location: Kamigyo-ku, Kyoto).

Press Release Materials (Japanese Only)

• 【プレスリリース】SIIFIC ウェルネスファンド、トレジェムバイオファーマに出資